论文部分内容阅读
目的:探讨原发性甲状旁腺功能亢进症(PHPT)合并甲状腺疾病的临床症状,为PHPT合并甲状腺疾病的诊治提供理论依据。方法:选取2014年5月-2016年6月在医院接受治疗的58例原发性甲状旁腺功能亢进症患者作为此次研究对象,采用回顾性分析方法对患者的临床资料进行分析,分析58例原发性甲状旁腺功能亢进症患者的B超和CT检查结果及原发性甲状旁腺功能亢进症合并甲状腺疾病患者的病情状况。结果:58例PHPT患者中合并甲状腺疾病患者30例,占比51.7%,单纯PHPT患者28例,占比48.3%;30例PHPT合并甲状腺疾病患者中结节性甲状腺肿18例,占比分别为60%和31%,甲状腺乳头状癌为8例,占比26.7%和13.8%,桥本氏甲状腺炎和甲状腺隐匿性癌均为2例,占比均分别为6.7%和3.4%。结论:原发性甲状旁腺功能亢进症合并甲状腺疾病患者的发病率非常高,易出现甲状腺恶性疾病,影响患者的诊治。
Objective: To explore the clinical symptoms of primary hyperparathyroidism (PHPT) complicated with thyroid diseases and to provide a theoretical basis for the diagnosis and treatment of PHPT complicated with thyroid diseases. Methods: Fifty-eight patients with primary hyperparathyroidism admitted to our hospital from May 2014 to June 2016 were selected as the study subjects. The clinical data of the patients were analyzed retrospectively. Cases of primary hyperparathyroidism in patients with B ultrasound and CT examination results and primary hyperparathyroidism with thyroid disease in patients with disease status. Results: There were 30 cases of PHPT patients with thyroid disease, accounting for 51.7%, 28 cases of pure PHPT patients, accounting for 48.3%; 30 cases of PHPT with thyroid disease in patients with nodular goiter in 18 cases, respectively 60% and 31% respectively. There were 8 cases of thyroid papillary carcinoma accounting for 26.7% and 13.8% respectively. There were 2 cases of Hashimoto’s thyroiditis and thyroid occult carcinoma, accounting for 6.7% and 3.4% respectively. Conclusion: The incidence of primary hyperparathyroidism complicated with thyroid disease is very high, prone to malignant thyroid disease, affecting the diagnosis and treatment of patients.